vs

Side-by-side financial comparison of ACCESS Newswire Inc. (ACCS) and UTAH MEDICAL PRODUCTS INC (UTMD). Click either name above to swap in a different company.

UTAH MEDICAL PRODUCTS INC is the larger business by last-quarter revenue ($9.0M vs $5.8M, roughly 1.6× ACCESS Newswire Inc.). UTAH MEDICAL PRODUCTS INC runs the higher net margin — 28.4% vs -9.9%, a 38.3% gap on every dollar of revenue. On growth, ACCESS Newswire Inc. posted the faster year-over-year revenue change (-0.5% vs -1.2%). Over the past eight quarters, ACCESS Newswire Inc.'s revenue compounded faster (2.0% CAGR vs -10.7%).

PR Newswire is a distributor of press releases headquartered in Chicago. The service was created in 1954 to allow companies to electronically send press releases to news organizations, using teleprinters at first. The founder, Herbert Muschel, operated the service from his house in Manhattan for approximately 15 years. The business was eventually sold to Western Union and then United Newspapers of London. In December 2015, Cision Inc. announced it would acquire the company. On January 1, 2021...

Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California. Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies software for managing cancer clinics, radiotherapy centers, and medical oncology practices. Varian Medical Systems employs more than 7,100 people at manufacturing sites...

ACCS vs UTMD — Head-to-Head

Bigger by revenue
UTMD
UTMD
1.6× larger
UTMD
$9.0M
$5.8M
ACCS
Growing faster (revenue YoY)
ACCS
ACCS
+0.8% gap
ACCS
-0.5%
-1.2%
UTMD
Higher net margin
UTMD
UTMD
38.3% more per $
UTMD
28.4%
-9.9%
ACCS
Faster 2-yr revenue CAGR
ACCS
ACCS
Annualised
ACCS
2.0%
-10.7%
UTMD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACCS
ACCS
UTMD
UTMD
Revenue
$5.8M
$9.0M
Net Profit
$-576.0K
$2.6M
Gross Margin
77.4%
58.2%
Operating Margin
-13.1%
27.0%
Net Margin
-9.9%
28.4%
Revenue YoY
-0.5%
-1.2%
Net Profit YoY
94.4%
-11.6%
EPS (diluted)
$-0.16
$0.80

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACCS
ACCS
UTMD
UTMD
Q4 25
$5.8M
$9.0M
Q3 25
$5.7M
$9.8M
Q2 25
$5.6M
$10.0M
Q1 25
$5.5M
$9.7M
Q4 24
$5.8M
$9.2M
Q3 24
$5.6M
$10.0M
Q2 24
$6.0M
$10.4M
Q1 24
$5.6M
$11.3M
Net Profit
ACCS
ACCS
UTMD
UTMD
Q4 25
$-576.0K
$2.6M
Q3 25
$-45.0K
$2.6M
Q2 25
$-475.0K
$3.0M
Q1 25
$5.4M
$3.0M
Q4 24
$-10.2M
$2.9M
Q3 24
$-466.0K
$3.6M
Q2 24
$7.0K
$3.5M
Q1 24
$-139.0K
$4.0M
Gross Margin
ACCS
ACCS
UTMD
UTMD
Q4 25
77.4%
58.2%
Q3 25
74.6%
57.1%
Q2 25
76.2%
56.2%
Q1 25
78.0%
57.0%
Q4 24
75.2%
58.1%
Q3 24
75.0%
58.0%
Q2 24
77.2%
60.1%
Q1 24
75.1%
59.7%
Operating Margin
ACCS
ACCS
UTMD
UTMD
Q4 25
-13.1%
27.0%
Q3 25
-3.2%
26.6%
Q2 25
-4.4%
32.1%
Q1 25
-12.4%
32.5%
Q4 24
-245.8%
32.0%
Q3 24
-10.7%
33.4%
Q2 24
-8.8%
33.1%
Q1 24
-15.5%
34.2%
Net Margin
ACCS
ACCS
UTMD
UTMD
Q4 25
-9.9%
28.4%
Q3 25
-0.8%
26.8%
Q2 25
-8.5%
30.6%
Q1 25
98.4%
31.3%
Q4 24
-175.0%
31.7%
Q3 24
-8.3%
35.6%
Q2 24
0.1%
33.2%
Q1 24
-2.5%
34.9%
EPS (diluted)
ACCS
ACCS
UTMD
UTMD
Q4 25
$-0.16
$0.80
Q3 25
$-0.01
$0.82
Q2 25
$-0.12
$0.94
Q1 25
$1.40
$0.92
Q4 24
$-2.66
$0.86
Q3 24
$-0.12
$1.03
Q2 24
$0.00
$0.98
Q1 24
$-0.04
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACCS
ACCS
UTMD
UTMD
Cash + ST InvestmentsLiquidity on hand
$3.0M
$85.8M
Total DebtLower is stronger
$225.0K
Stockholders' EquityBook value
$30.3M
$119.3M
Total Assets
$42.0M
$122.5M
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACCS
ACCS
UTMD
UTMD
Q4 25
$3.0M
$85.8M
Q3 25
$3.3M
$84.3M
Q2 25
$82.2M
Q1 25
$83.3M
Q4 24
$4.1M
$83.0M
Q3 24
$88.5M
Q2 24
$89.2M
Q1 24
$93.8M
Total Debt
ACCS
ACCS
UTMD
UTMD
Q4 25
$225.0K
Q3 25
Q2 25
Q1 25
$269.0K
Q4 24
$282.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ACCS
ACCS
UTMD
UTMD
Q4 25
$30.3M
$119.3M
Q3 25
$30.8M
$118.3M
Q2 25
$30.7M
$117.5M
Q1 25
$30.9M
$117.0M
Q4 24
$25.2M
$117.4M
Q3 24
$35.3M
$124.2M
Q2 24
$35.4M
$124.1M
Q1 24
$35.2M
$127.7M
Total Assets
ACCS
ACCS
UTMD
UTMD
Q4 25
$42.0M
$122.5M
Q3 25
$44.0M
$122.0M
Q2 25
$45.6M
$120.8M
Q1 25
$47.3M
$122.5M
Q4 24
$50.6M
$122.5M
Q3 24
$61.7M
$129.7M
Q2 24
$62.8M
$130.0M
Q1 24
$64.4M
$135.4M
Debt / Equity
ACCS
ACCS
UTMD
UTMD
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACCS
ACCS
UTMD
UTMD
Operating Cash FlowLast quarter
$258.0K
$3.5M
Free Cash FlowOCF − Capex
$3.4M
FCF MarginFCF / Revenue
37.2%
Capex IntensityCapex / Revenue
0.0%
1.2%
Cash ConversionOCF / Net Profit
1.36×
TTM Free Cash FlowTrailing 4 quarters
$14.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACCS
ACCS
UTMD
UTMD
Q4 25
$258.0K
$3.5M
Q3 25
$-582.0K
$3.9M
Q2 25
$135.0K
$2.9M
Q1 25
$747.0K
$4.5M
Q4 24
$866.0K
$2.9M
Q3 24
$1.5M
$3.9M
Q2 24
$-190.0K
$2.8M
Q1 24
$986.0K
$5.3M
Free Cash Flow
ACCS
ACCS
UTMD
UTMD
Q4 25
$3.4M
Q3 25
$-590.0K
$3.9M
Q2 25
$2.8M
Q1 25
$735.0K
$4.3M
Q4 24
$2.9M
Q3 24
$1.5M
$3.8M
Q2 24
$2.7M
Q1 24
$970.0K
$5.3M
FCF Margin
ACCS
ACCS
UTMD
UTMD
Q4 25
37.2%
Q3 25
-10.3%
39.2%
Q2 25
28.4%
Q1 25
13.4%
44.1%
Q4 24
32.0%
Q3 24
26.5%
37.7%
Q2 24
25.5%
Q1 24
17.4%
46.3%
Capex Intensity
ACCS
ACCS
UTMD
UTMD
Q4 25
0.0%
1.2%
Q3 25
0.1%
0.3%
Q2 25
0.0%
0.5%
Q1 25
0.2%
1.9%
Q4 24
0.0%
0.1%
Q3 24
0.1%
0.9%
Q2 24
0.0%
1.1%
Q1 24
0.3%
0.2%
Cash Conversion
ACCS
ACCS
UTMD
UTMD
Q4 25
1.36×
Q3 25
1.47×
Q2 25
0.94×
Q1 25
0.14×
1.47×
Q4 24
1.01×
Q3 24
1.08×
Q2 24
-27.14×
0.80×
Q1 24
1.33×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACCS
ACCS

Cost To Deliver Products$3.1M54%
Employee Costs$1.7M29%
Other$1.0M17%

UTMD
UTMD

Segment breakdown not available.

Related Comparisons